સરકારી યોજના , સરકારી ભરતી અને લેટેસ્ટ ન્યૂઝ માટે અમારા વોટ્સઅપ નંબર +91 94093 54409 ને તમારા વોટ્સએપ ગ્રુપ માં એડ કરો

Search This Website

Sunday, 6 December 2020

India pre-orders vaccine dose of Rs 160 crore; 60% of the population will be covered

Vaccine Tracker: India pre-orders vaccine dose of Rs 160 crore; 60% of the population will be covered




Global Analysis claims that India has the largest pre-order of vaccines in the world
This is followed by pre-orders of vaccines from the European Union, the United States and other countries



In the fight against the corona virus, China has given emergency approval to 4 vaccines, Russia 2 and UK A 1 vaccine. In India, even though the vaccine has not received approval, they are at the forefront of pre-orders. According to a global analysis, India has secured 160 crore doses. Experts say that this will cover 800 million people, i.e. 60% of our country's population. This is enough to develop herd immunity.


According to the launch and scale speedometer analysis, which is updated every two weeks, India has secured 160 crore doses of these three vaccines till November 30. After India, 158 crore doses of EU and 100 crore doses of US have been secured. According to the Duke University Global Health Innovation Center in the United States, India has agreed to purchase 500 million doses of the Oxford University-AstraZeneca covshield vaccine. So, India is going to get 100 crore doses of US company NovoVex and 100 crore doses of Sputnik V vaccine from Gamaleya Research Institute of Russia. Duke researchers said in the analysis that manufacturing potential countries such as India and Brazil have gained a large number of market commitments from major vaccine candidates. Even before these candidates' vaccines hit the market.



The poorest countries are completely dependent on the WHO,
according to a report by Duke University. High-income countries have secured 380 million doses. Upper middle income countries secured 829 million doses and lower middle income countries received 170 million doses. Researchers say low-income countries have made no direct deals. That means 20% of the population is totally dependent on the Covex. COVAX is an initiative of the World Health Organization, the Coalition for Endemic Preparatory Innovations (CEPI) and the International Vaccine Alliance Organization Gavi, which aims to make Covid-19 available to all countries, including governments and vaccine manufacturers.




Vaccines ordered up to five times the population
Many countries have pre-ordered more vaccines than their population, according to an analysis by Global Researchers. Canada has 527% more vaccines than its population, followed by the UK at 288%, Australia at 266%, Chile at 223%, the European Union at 199%, the USA at 169% and Japan at 115%. This is because even if a vaccine fails and does not reach the approval stage, the population will not be deprived of the vaccine. So it seems that the vaccine will reach only 60% of the population in India.

Also, read  WFVS: Upload Full Whatsapp Video Status

Only a few rich countries should not have the right to vaccines
Experts working in the field of public health have urged leaders around the world to understand the responsibility for Kovid-19 as well as future diseases. So that the right to cure or vaccine for Covid-19 does not remain with only a select few rich countries.


Also read 

Avast Antivirus – Mobile Security & Virus Cleane



 Led by the George Institute for Global Health in India, 400 other institutions have joined hands with global leaders. This includes Jawaharlal Nehru University's Department of Public Health and Social Justice. Kakkade, MD, an anesthesiologist and critical care at PGIMS Rohtak, said that according to news reports, the sea and rich countries have claimed 70% of the vaccine. Each country is trying to get as many vaccines as possible for its population. 





Hyderabad and Delhi airports are also ready for vaccine transportation.
Air cargo services at Delhi and Hyderabad airports are also fully ready for vaccine distribution. Delhi Airport has two cargo terminals. There a state-of-the-art time and temperature-sensitive distribution system will play a special role in the distribution for vaccines. Delhi Airport has the capacity to handle 1.5 lakh metric tonnes of cargo every year. 


Which has a temperature-controlled zone ranging from -20 degrees to 25 degrees Celsius. GMR Hyderabad Air Cargo is the first pharma zone in India to have a GDP-certified temperature controlled facility, a Hyderabad Airport spokesperson said.

No comments:

Post a comment